Pagibaximab
Trade name: aurograb
mAbexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2004 (NCT00217841)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- ABC transporter GrfAINHIBITOR
ABC transporter GrfA inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109569 ↗
Also known as
- aurograb
- aurograb
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00217841 | Phase 3 | Jan 1, 2004 | NeuTec Pharma, University of Leeds |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| NeuTec Pharma | For profit | 1 | 1 | 1 | 2004 |
| University of Leeds | Academic/Hospital | 1 | 0 | 1 | 2004 |
2 organizations
Page 1 / 1